This looks promising. We know that the virus increases levels of the anti-inflammatory cytokine IL-6. Early results are coming out that treating patients with an IL-6 monoclonal antibody, normally used for rheumatoid arthritis, helps. But you don't want to know how much it costs.
https://www.pharmaceutical-technology.com/news/roche-actemra-coronavirus-complications/
